Form 8-K - Current report:
SEC Accession No. 0001493152-26-035682
Filing Date
2026-07-31
Accepted
2026-07-31 17:26:20
Documents
14
Period of Report
2026-07-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 54393
2 EX-4.1 ex4-1.htm EX-4.1 129244
3 EX-10.1 ex10-1.htm EX-10.1 178921
  Complete submission text file 0001493152-26-035682.txt   634847

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE cdt-20260730.xsd EX-101.SCH 3826
5 XBRL DEFINITION FILE cdt-20260730_def.xml EX-101.DEF 26703
6 XBRL LABEL FILE cdt-20260730_lab.xml EX-101.LAB 36865
7 XBRL PRESENTATION FILE cdt-20260730_pre.xml EX-101.PRE 25327
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5524
Mailing Address 4851 TAMIAMI TRAIL NORTH SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL NORTH SUITE 200 NAPLES FL 34103 (646) 491 9132
CDT Equity Inc. (Filer) CIK: 0001896212 (see all company filings)

EIN.: 873272543 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41245 | Film No.: 261229592
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)